774.33美元8.02(1.05%)
2024/07/25更新
績效 / 1月4.04%
3月21.3%
1年12.66%
晨星評等 - 1.現金0.42%
- 2.股票13.11%
- 3.債券0.00%
- 4.其他86.47%
- 1.美國86.47%
- 2.歐洲不包含歐元區7.40%
- 3.歐元區4.38%
- 4.英國1.33%
- 1.Regeneron Pharmaceuticals Inc9.85%
- 2.Alnylam Pharmaceuticals Inc9.69%
- 3.Vertex Pharmaceuticals Inc9.29%
- 4.Moderna Inc7.00%
- 5.Neurocrine Biosciences Inc4.69%
- 6.Amgen Inc4.58%
- 7.Guardant Health Inc4.26%
- 8.Blueprint Medicines Corp3.88%
- 9.Genmab A/S3.69%
- 10.AbbVie Inc3.47%
- 1.現金0.42%
- 2.股票13.11%
- 3.債券0.00%
- 4.其他86.47%
- 1.美國86.47%
- 2.歐洲不包含歐元區7.40%
- 3.歐元區4.38%
- 4.英國1.33%
- 1.Regeneron Pharmaceuticals Inc9.85%
- 2.Alnylam Pharmaceuticals Inc9.69%
- 3.Vertex Pharmaceuticals Inc9.29%
- 4.Moderna Inc7.00%
- 5.Neurocrine Biosciences Inc4.69%
- 6.Amgen Inc4.58%
- 7.Guardant Health Inc4.26%
- 8.Blueprint Medicines Corp3.88%
- 9.Genmab A/S3.69%
- 10.AbbVie Inc3.47%